LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,000 | -26.7% | 7,000 | 0.0% | 0.00% | – |
| Q1 2022 | $30,000 | -9.1% | 7,000 | 0.0% | 0.00% | – |
| Q4 2021 | $33,000 | +17.9% | 7,000 | 0.0% | 0.00% | – |
| Q3 2021 | $28,000 | -6.7% | 7,000 | 0.0% | 0.00% | – |
| Q2 2021 | $30,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q1 2021 | $30,000 | +11.1% | 7,000 | 0.0% | 0.00% | – |
| Q4 2020 | $27,000 | -3.6% | 7,000 | 0.0% | 0.00% | – |
| Q3 2020 | $28,000 | -6.7% | 7,000 | 0.0% | 0.00% | – |
| Q2 2020 | $30,000 | +3.4% | 7,000 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | +3.6% | 7,000 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | -20.0% | 7,000 | +74.2% | 0.00% | – |
| Q3 2019 | $35,000 | -5.4% | 4,019 | 0.0% | 0.00% | – |
| Q2 2019 | $37,000 | -57.0% | 4,019 | +40.5% | 0.00% | – |
| Q1 2017 | $86,000 | – | 2,860 | +9125.8% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 31 | -3.1% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 32 | +3.2% | 0.00% | – |
| Q4 2015 | $1,000 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |